VTP-1000

N/A

Report date: 2026/03/06 20:02:51

Base Information

Drug NameVTP-1000
Drug Alias Nameself-assembling nanoparticles of gluten peptides and a rapamycin component (Barinthus Biotherapeutics)VTP-1000
ClassificationSmall molecules
Mechanisms of ActionT lymphocytes stimulantsImmunostimulantsSerine/threonine-protein kinase mTOR inhibitors
TargetsSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsCeliac Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBarinthus Biotherapeutics PLC
China Registration ClassN/A

Develop Information

Active CompaniesBarinthus Biotherapeutics PLC
Inactive CompaniesN/A
Active IndicationsCeliac Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A